Literature DB >> 22791907

Activation of Stat3 in endothelial cells following hypoxia-reoxygenation is mediated by Rac1 and protein Kinase C.

Subhendra N Mattagajasingh1, Xiao Ping Yang, Kaikobad Irani, Ilwola Mattagajasingh, Lewis C Becker.   

Abstract

Stat3 is an important transcription factor that regulates both proinflammatory and anit-apoptotic pathways in the heart. This study examined the mechanisms of activation of Stat3 in human endothelial cells following hypoxia/reoxygenation (H/R). By expression of constitutively active Rac1 mutant protein, and by RNA silencing of Rac1, we found that Stat3 forms a multiprotein complex with Rac1 and PKC in an H/R-dependent manner, which at least in part, appears to regulate Stat3 S727 phosphorylation. Selective inhibition of PKC with calphostin C produces a marked suppression of Stat3 S727 phosphorylation. The association of Stat3 with Rax1 occurs predominantly at the cell membrane, but also inside the nucleus, and occurs through the binding of the coiled-coil domain of Stat3 to the 54 NH(2)-terminal residues of Rac1. Transfection with a peptide comprising the NH(2)-terminal 17 amino acid residues of Rac1-dependent signaling pathways resulting in physical association between Rac1 and Stat3 and the formation of a novel multiprotein complex with PKC.

Entities:  

Keywords:  Stat3; endothelial cells; inflammation; protein kinase C; protein-protein interaction; reactive oxygen species

Mesh:

Substances:

Year:  2012        PMID: 22791907      PMCID: PMC3392026          DOI: 10.1016/j.bbamcr.2012.02.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

1.  Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1.

Authors:  A Abo; E Pick; A Hall; N Totty; C G Teahan; A W Segal
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

2.  Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.

Authors:  E Kobayashi; H Nakano; M Morimoto; T Tamaoki
Journal:  Biochem Biophys Res Commun       Date:  1989-03-15       Impact factor: 3.575

3.  STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1.

Authors:  M David; L Wong; R Flavell; S A Thompson; A Wells; A C Larner; G R Johnson
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

Review 4.  Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteins.

Authors:  G M Bokoch
Journal:  Curr Opin Cell Biol       Date:  1994-04       Impact factor: 8.382

5.  Chelerythrine is a potent and specific inhibitor of protein kinase C.

Authors:  J M Herbert; J M Augereau; J Gleye; J P Maffrand
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

Review 6.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

Review 7.  Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.

Authors:  Guro Valen
Journal:  Basic Res Cardiol       Date:  2003-10-30       Impact factor: 17.165

8.  Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury.

Authors:  Denise Hilfiker-Kleiner; Andres Hilfiker; Martin Fuchs; Karol Kaminski; Arnd Schaefer; Bernhard Schieffer; Anja Hillmer; Andreas Schmiedl; Zhaoping Ding; Edith Podewski; Eva Podewski; Valeria Poli; Michael D Schneider; Rainer Schulz; Joon-Keun Park; Kai C Wollert; Helmut Drexler
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

9.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions.

Authors:  K Shuai; C M Horvath; L H Huang; S A Qureshi; D Cowburn; J E Darnell
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

10.  Rac GTPase interacts with GAPs and target proteins through multiple effector sites.

Authors:  D Diekmann; C D Nobes; P D Burbelo; A Abo; A Hall
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  6 in total

1.  Acute systemic insulin intolerance does not alter the response of the Akt/GSK-3 pathway to environmental hypoxia in human skeletal muscle.

Authors:  Gommaar D'Hulst; Lykke Sylow; Peter Hespel; Louise Deldicque
Journal:  Eur J Appl Physiol       Date:  2015-01-11       Impact factor: 3.078

2.  Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.

Authors:  Matthew R Farren; Louise M Carlson; Colleen S Netherby; Inna Lindner; Pui-Kai Li; Dmitry I Gabrilovich; Scott I Abrams; Kelvin P Lee
Journal:  Sci Signal       Date:  2014-02-18       Impact factor: 8.192

3.  JAK2/STAT3 inhibition attenuates noise-induced hearing loss.

Authors:  Teresa Wilson; Irina Omelchenko; Sarah Foster; Yuan Zhang; Xiaorui Shi; Alfred L Nuttall
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

4.  Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3-NFκB complexes in starved cancer cells.

Authors:  Sung Joo Kim; Sarah Yoon
Journal:  Exp Mol Med       Date:  2016-05-06       Impact factor: 8.718

5.  An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.

Authors:  Zhe Zhang; Zhiyong Luo; Wenpu Min; Lin Zhang; Yaqun Wu; Xiaopeng Hu
Journal:  Oncotarget       Date:  2017-06-27

6.  LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis.

Authors:  Yirong Wang; Siqi Wu; Xun Zhu; Liyuan Zhang; Jieqiong Deng; Fang Li; Binbin Guo; Shenghua Zhang; Rui Wu; Zheng Zhang; Kexin Wang; Jiachun Lu; Yifeng Zhou
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.